Dublin, Feb. 27, 2024 (GLOBE NEWSWIRE) -- The 'Automation in Biopharma Industry Market - Global Industry Size, Share, Trends, Opportunity, & Forecast 2018-2028' report has been added to ResearchAndMarkets.com's offering. In a new comprehensive research study, insights into the Automation in Biopharma Industry Market reveal an upward trajectory from USD 1775.20 million in 2022 to an anticipated USD 2468.19 million by 2028.

都柏林，2024年2月27日（环球通讯社）——ResearchAndMarkets.com发布了“2018-2028年生物制药行业市场自动化-全球行业规模、份额、趋势、机会和预测”报告。在一项新的综合研究中，对生物制药行业市场自动化的深入了解显示，从2022年的17.752亿美元上升到2028年的预计24.6819亿美元。

The sector spots a projected Compound Annual Growth Rate (CAGR) of 5.80% over the six-year period. The augmentation of the market is fueled by advancements in automation technologies and an increasing demand for high-throughput screening, alongside the rising complexity of biopharmaceuticals. Market dynamics highlight significant growth drivers, such as the integration of advanced robotics, lab-on-a-chip technologies, and the employment of artificial intelligence and machine learning.

该行业预计六年内复合年增长率（CAGR）为5.80%。自动化技术的进步和对高通量筛选的需求不断增加，以及生物制药的复杂性不断提高，推动了市场的扩大。市场动态突出了重要的增长驱动因素，例如先进机器人技术、芯片实验室技术的集成以及人工智能和机器学习的应用。

Evolving biopharma products' complexity necessitates advanced automation to ensure consistent high-quality output, bolstering the market's robust expansion. Technological Advancements and Process Analytical Technology Shape the Biopharmaceutical Landscape Advancements in digitization and automation technology promote the seamless conduct of biopharmaceutical processes.Robotics and artificial intelligence streamline operations, enhancing drug discovery and development efficiencies.Process Analytical Technology (PAT) ensures real-time control and monitoring, fortifying quality assurance in biopharma manufacturing.

不断发展的生物制药产品的复杂性需要先进的自动化来确保一致的高质量输出，从而支持市场的强劲扩张。技术进步和过程分析技术塑造了生物制药的格局数字化和自动化技术的进步促进了生物制药过程的无缝进行。机器人技术和人工智能简化了操作，提高了药物发现和开发效率。过程分析技术（PAT）确保了实时控制和监测，加强了生物制药制造中的质量保证。

Complex Biopharmaceuticals Surge Demand for Precision Automation As therapies become more intricate, the necessity for precise automation escalates, maintaining product quality and regulatory compliance.The move towards personalized medicines heightens the nee.

复杂的生物制药对精确自动化的需求激增随着治疗变得更加复杂，精确自动化的必要性不断升级，保持产品质量和法规遵从性。个性化药物的发展提高了nee。

Attachment

附件

Global Automation in Biopharma Industry Market

生物制药行业市场的全球自动化